DSM-5 Substance Use Disorder Diagnostic Criteria
A diagnosis of substance use disorder requires meeting at least 2 of 11 criteria within a 12-month period, with severity graded as mild (2-3 criteria), moderate (4-5 criteria), or severe (6 or more criteria). 1
The 11 Diagnostic Criteria
The DSM-5 consolidated the previous DSM-IV abuse and dependence categories into a single dimensional diagnosis based on these criteria:
Impaired Control (Criteria 1-4)
- Taking larger amounts or for longer periods than intended
- Persistent desire or unsuccessful efforts to cut down or control use
- Significant time spent obtaining, using, or recovering from the substance
- Craving or strong desire to use the substance (newly added in DSM-5)
Social Impairment (Criteria 5-7)
- Failure to fulfill major role obligations at work, school, or home
- Continued use despite persistent social or interpersonal problems
- Important activities given up or reduced because of substance use
Risky Use (Criteria 8-9)
- Recurrent use in physically hazardous situations
- Continued use despite knowledge of physical or psychological problems caused or exacerbated by the substance
Pharmacological Criteria (Criteria 10-11)
- Tolerance (need for increased amounts or diminished effect with same amount)
- Withdrawal (characteristic withdrawal syndrome or substance taken to relieve withdrawal)
Diagnostic Threshold and Severity Grading
The diagnostic threshold is set at 2 or more criteria to maximize identification of all cases requiring intervention, including milder presentations commonly seen in primary care settings 1. This threshold showed optimal agreement with DSM-IV diagnoses while maintaining similar prevalence rates 1.
Severity is determined by simple criterion count 1:
- Mild: 2-3 criteria met
- Moderate: 4-5 criteria met
- Severe: 6 or more criteria met
This straightforward counting approach proved superior to weighted scoring systems, as criterion counts correlate directly with risk factors, consequences, consumption levels, and functional impairment 1.
Critical Exception: Medically Supervised Use
Do not diagnose substance use disorder based solely on tolerance and withdrawal in patients receiving supervised medical treatment with psychoactive substances (opioids, stimulants, benzodiazepines, cannabis in some jurisdictions) 1. These represent normal physiological adaptations to prescribed medications and require additional criteria for a valid diagnosis.
Key Changes from DSM-IV
The DSM-5 made several important modifications 1:
- Eliminated the "legal problems" criterion (poor predictive validity)
- Added craving as a new criterion (criterion 4)
- Combined abuse and dependence into single dimensional diagnosis
- Removed the physiological specifier (inconsistent predictive value)
- Simplified remission specifiers to early (≥3 to <12 months) and sustained (≥12 months), allowing craving to persist during remission
Clinical Application Considerations
Research demonstrates that criteria 1,2,4,9,10, and 11 show the strongest association with substance use disorder diagnosis across substances 2. The unidimensional nature of these criteria has been validated across alcohol, cannabis, cocaine, and heroin 2.
Among the 11 criteria, "craving," "large amount," "time spent," "tolerance," and "activities given up" function consistently across different care settings (harm reduction vs. treatment-seeking populations), while consequence-related criteria may show differential functioning 3.
In elderly populations (≥80 years), criteria 1,4,6,9,10, and 11 demonstrate the strongest association with addiction diagnosis, suggesting these may be most relevant when evaluating older adults 4.
Remission Specifiers
- Early remission: ≥3 to <12 months without meeting criteria (except craving)
- Sustained remission: ≥12 months without meeting criteria (except craving)
- Additional specifiers: "in a controlled environment" or "on maintenance therapy" (e.g., methadone, buprenorphine, naltrexone, varenicline, bupropion) 1